Patent US4725550A successfully refreshed from Google Patents.
US4725550A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma
Assignee: Research Foundation of the State University of New York
•
Filing: 1984-01-19
•
Granted: 1988-02-16
•
Expires: 2004-01-19
Abstract
Abstract A c-Kirsten _r oncogene has been isolated from a human lung tumor cell line. This c-Kirsten _r has a mutation in codon 61 of the second coding exon and is capable of transforming NIH/3T3 mouse fibroblast cells to tumorigenic cells.
Inventors
- 👤 Manuel Perucho
- 👤 Hirofumi Nakano
- 👤 Fumiichiro Yamamoto
- 👤 Craig Neville
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 12:38
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/82; A; A61; A61P; A61P43/00
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
31 words
Purified DNA from a human c-K ras gene capable of transforming NIH3T3 mouse fibroblast cells to tumorigneic cells, said DNA containing a mutation in codon 61 of the second exon thereof.
Claim 2
Dependent Claim
31 words
Purified DNA from a human c-K ras gene capable of transforming NIH3T3 mouse fibroblast cells to tumorigneic cells, said DNA containing a mutation in codon 61 of the second exon thereof.
Claim 3
Dependent Claim
23 words
Purified DNA of claim 1 wherein the c-K ras gene is derived from the human lung carcinoma line PR 310 (ATCC CRL- 8477).
Claim 4
Dependent Claim
15 words
Purified DNA of claim 1 wherein the mutation is a transversion in said codon 61.
Claim 5
Dependent Claim
17 words
Purified DNA of claim 3 wherein the transversion is in the third base of said codon 61.
Claim 6
Dependent Claim
12 words
Purified DNA of claim 4 wherein the transversion is an A→T transversion.
Claim 7
Dependent Claim
158 words
Purified DNA comprising the nucleotide sequence: __________________________________________________________________________
ATG ACT GAA TAT AAA CTT GTG GTA GTT GGA GCT GGT GGC GTA GGC
AAG AGT GCC TTG ACG ATA CAG CTA ATT CAG AAT CAT TTT GTG GAC
GAA TAT GAT CCA ACA ATA GAG GAT TCC TAC AGG AAG CAA GTA GTA
ATT GAT GGA GAA ACC TGT CTC TTG GAT ATT CTC GAG ACA GCA GGT
CAT GAG GAG TAC AGT GCA ATG AGG GAC CAG TAC ATG AGG ACT GGG
GAG GGC TTT CTT TGT GTA TTT GCC ATA AAT AAT ACT AAA TCA TTT
GAA GAT ATT CAC CAT TAT AGA GAA CAA ATT AAA AGA GTT AAG GAC
TCT GAA GAT GTA CCT ATG GTC CTA GTA GGA AAT AAA TGT GAT TTG
CCT TCT AGA ACA GTA GAC ACA AAA CAG GCT CAG GAC TTA GCA AGA
AGT TAT GGA ATT CCT TTT ATT GAA ACA TCA GCA AAG ACA AGA
__________________________________________________________________________
CAG
Claim 8
Dependent Claim
158 words
Purified DNA comprising the nucleotide sequence: __________________________________________________________________________
ATG ACT GAA TAT AAA CTT GTG GTA GTT GGA GCT GGT GGC GTA GGC
AAG AGT GCC TTG ACG ATA CAG CTA ATT CAG AAT CAT TTT GTG GAC
GAA TAT GAT CCA ACA ATA GAG GAT TCC TAC AGG AAG CAA GTA GTA
ATT GAT GGA GAA ACC TGT CTC TTG GAT ATT CTC GAG ACA GCA GGT
CAT GAG GAG TAC AGT GCA ATG AGG GAC CAG TAC ATG AGG ACT GGG
GAG GGC TTT CTT TGT GTA TTT GCC ATA AAT AAT ACT AAA TCA TTT
GAA GAT ATT CAC CAT TAT AGA GAA CAA ATT AAA AGA GTT AAG GAC
TCT GAA GAT GTA CCT ATG GTC CTA GTA GGA AAT AAA TGT GAT TTG
CCT TCT AGA ACA GTA GAC ACA AAA CAG GCT CAG GAC TTA GCA AGA
AGT TAT GGA ATT CCT TTT ATT GAA ACA TCA GCA AAG ACA AGA
__________________________________________________________________________
CAG
Claim 9
Dependent Claim
15 words
Purified DNA of claim 1 having the partial nucleotide sequence of the second coding exon.
Claim 10
Dependent Claim
15 words
Purified DNA of claim 2 having the partial nucleotide sequence of the second coding exon.
Claim 11
Dependent Claim
15 words
Purified DNA of claim 6 having the partial nucleotide sequence of the second coding exon.
Claim 12
Dependent Claim
9 words
A cloning vector containing the DNA of claim 1.
Claim 13
Dependent Claim
13 words
The cloning vector of claim 10 which is a bacterial plasmid or bacteriophage.
Claim 14
Dependent Claim
11 words
The cloning vector of claim 11 which is a pBR322 plasmid.
Claim 15
Dependent Claim
9 words
A cloning vector containing the DNA of claim 2.
Claim 16
Dependent Claim
13 words
The cloning vector of claim 13 which is a bacterial plasmid or bacteriophage.
Claim 17
Dependent Claim
11 words
The cloning vector of claim 14 which is a pBR322 plasmid.
Claim 18
Dependent Claim
9 words
A cloning vector containing the DNA of claim 6.
Claim 19
Dependent Claim
13 words
The cloning vector of claim 16 which is a bacterial plasmid or bacteriophage.
Claim 20
Dependent Claim
11 words
The cloning vector of claim 17 which is a pBR322 plasmid.
References Cited (Backward Citations)
US4535058A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-02-15 | 1991-08-17 | 1992-02-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-02-15 | 1995-08-17 | 1996-02-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-02-15 | 1999-08-17 | 2000-02-16 | $7700.00 | Window Closed / Lapsed |